Follow the people · Insider
Yann Mazabraud
Yann Mazabraud files insider transactions with the SEC as an evp, head of international of Rhythm Pharmaceuticals (RYTM). We hold 1 disclosed purchase or sale filed since 5 June 2019, 1 of them in the last 90 days.
- Files forRYTM
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure14 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 5 October 2020 — 12 August 2026EVP, Head of International · Rhythm Pharmaceuticals (RYTM)73 Form 4 lines · source: SEC Form 4
- Filed 3 June 2019 — 13 February 2020Officer · Trevi Therapeutics (TRVI)2 Form 4 lines · source: SEC Form 4
Everything they disclosed
75 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 46,625 shares of Rhythm PharmaceuticalsSEC Form 414 August 2026Common Stock · traded 12 August 2026 · filed 14 August 2026
- ▼ sold on the open market 2,300 shares of Rhythm PharmaceuticalsSEC Form 414 August 2026Common Stock · traded 12 August 2026 · filed 14 August 2026
- ▼ sold on the open market 1,000 shares of Rhythm PharmaceuticalsSEC Form 414 August 2026Common Stock · traded 12 August 2026 · filed 14 August 2026
- ▼ sold on the open market 3,605 shares of Rhythm PharmaceuticalsSEC Form 414 August 2026Common Stock · traded 12 August 2026 · filed 14 August 2026
- ▼ sold on the open market 14,568 shares of Rhythm PharmaceuticalsSEC Form 414 August 2026Common Stock · traded 12 August 2026 · filed 14 August 2026
- ▼ sold on the open market 18,208 shares of Rhythm PharmaceuticalsSEC Form 414 August 2026Common Stock · traded 12 August 2026 · filed 14 August 2026
- ▼ sold on the open market 17,319 shares of Rhythm PharmaceuticalsSEC Form 414 August 2026Common Stock · traded 12 August 2026 · filed 14 August 2026
- exercised options over 46,625 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 414 August 2026Stock Options (Right to Buy) · traded 12 August 2026 · filed 14 August 2026
- exercised options over 12,875 shares of Rhythm PharmaceuticalsSEC Form 43 April 2026Common Stock · traded 1 April 2026 · filed 3 April 2026
- exercised options over 10,375 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 April 2026Restricted Stock Units · traded 1 April 2026 · filed 3 April 2026
- exercised options over 2,500 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 April 2026Restricted Stock Units · traded 1 April 2026 · filed 3 April 2026
- was granted 35,000 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 44 March 2026Stock Options (Right to Buy) · traded 2 March 2026 · filed 4 March 2026
- was granted 35,000 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 44 March 2026Stock Options (Right to Buy) · traded 2 March 2026 · filed 4 March 2026
- exercised options over 10,000 shares of Rhythm PharmaceuticalsSEC Form 418 February 2026Common Stock · traded 14 February 2026 · filed 18 February 2026
- exercised options over 10,000 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 418 February 2026Restricted Stock Units · traded 14 February 2026 · filed 18 February 2026
- exercised options over 10,000 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 418 February 2026Restricted Stock Units · traded 14 February 2026 · filed 18 February 2026
- exercised options over 10,000 shares of Rhythm PharmaceuticalsSEC Form 418 February 2026Common Stock · traded 14 February 2026 · filed 18 February 2026
- was granted 23,350 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 February 2026Restricted Stock Units · traded 11 February 2026 · filed 13 February 2026
- was granted 23,350 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 February 2026Restricted Stock Units · traded 11 February 2026 · filed 13 February 2026
- exercised options over 5,500 shares of Rhythm PharmaceuticalsSEC Form 43 February 2026Common Stock · traded 1 February 2026 · filed 3 February 2026
- exercised options over 5,500 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 1 February 2026 · filed 3 February 2026
- exercised options over 5,500 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 1 February 2026 · filed 3 February 2026
- exercised options over 5,500 shares of Rhythm PharmaceuticalsSEC Form 43 February 2026Common Stock · traded 1 February 2026 · filed 3 February 2026
- ▼ sold on the open market 6,745 shares of Rhythm PharmaceuticalsSEC Form 41 May 2025Common Stock · traded 29 April 2025 · filed 1 May 2025
- exercised options over 10,375 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 416 April 2025Restricted Stock Units · traded 14 April 2025 · filed 16 April 2025
- exercised options over 8,905 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 416 April 2025Restricted Stock Units · traded 15 April 2025 · filed 16 April 2025
- exercised options over 2,500 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 416 April 2025Restricted Stock Units · traded 15 April 2025 · filed 16 April 2025
- exercised options over 10,375 shares of Rhythm PharmaceuticalsSEC Form 416 April 2025Common Stock · traded 14 April 2025 · filed 16 April 2025
- exercised options over 11,405 shares of Rhythm PharmaceuticalsSEC Form 416 April 2025Common Stock · traded 15 April 2025 · filed 16 April 2025
- ▼ sold on the open market 8,438 shares of Rhythm PharmaceuticalsSEC Form 410 April 2025Common Stock · traded 8 April 2025 · filed 10 April 2025
- ▼ sold on the open market 9,312 shares of Rhythm PharmaceuticalsSEC Form 410 April 2025Common Stock · traded 8 April 2025 · filed 10 April 2025
- exercised options over 75,000 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 418 March 2025Stock Options (Right to Buy) · traded 14 March 2025 · filed 18 March 2025
- exercised options over 75,000 shares of Rhythm PharmaceuticalsSEC Form 418 March 2025Common Stock · traded 14 March 2025 · filed 18 March 2025
- ▼ sold on the open market 19,197 shares of Rhythm PharmaceuticalsSEC Form 418 March 2025Common Stock · traded 14 March 2025 · filed 18 March 2025
- ▼ sold on the open market 55,803 shares of Rhythm PharmaceuticalsSEC Form 418 March 2025Common Stock · traded 14 March 2025 · filed 18 March 2025
- was granted 40,000 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 419 February 2025Restricted Stock Units · traded 14 February 2025 · filed 19 February 2025
- was granted 60,000 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 419 February 2025Stock Options (Right to Buy) · traded 14 February 2025 · filed 19 February 2025
- exercised options over 5,500 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 419 February 2025Restricted Stock Units · traded 16 February 2025 · filed 19 February 2025
- exercised options over 5,500 shares of Rhythm PharmaceuticalsSEC Form 419 February 2025Common Stock · traded 16 February 2025 · filed 19 February 2025
- exercised options over 10,375 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 416 April 2024Restricted Stock Units · traded 14 April 2024 · filed 16 April 2024
- returned to the issuer 2,031 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 416 April 2024Restricted Stock Units · traded 15 April 2024 · filed 16 April 2024
- returned to the issuer 6,874 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 416 April 2024Restricted Stock Units · traded 15 April 2024 · filed 16 April 2024
- was granted 8,905 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 416 April 2024Restricted Stock Units · traded 15 April 2024 · filed 16 April 2024
- was granted 10,000 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 416 April 2024Restricted Stock Units · traded 15 April 2024 · filed 16 April 2024
- exercised options over 10,375 shares of Rhythm PharmaceuticalsSEC Form 416 April 2024Common Stock · traded 14 April 2024 · filed 16 April 2024
- ▼ sold on the open market 16,000 shares of Rhythm PharmaceuticalsSEC Form 419 March 2024Common Stock · traded 19 March 2024 · filed 19 March 2024
- was granted 22,000 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 421 February 2024Restricted Stock Units · traded 16 February 2024 · filed 21 February 2024
- was granted 67,000 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 421 February 2024Stock Option (Right to Buy) · traded 16 February 2024 · filed 21 February 2024
- was granted 33,750 shares of Rhythm PharmaceuticalsSEC Form 421 February 2024Common Stock · traded 16 February 2024 · filed 21 February 2024
- exercised options over 3,438 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 February 2024Restricted Stock Units · traded 9 February 2024 · filed 13 February 2024
- exercised options over 2,031 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 February 2024Restricted Stock Units · traded 11 February 2024 · filed 13 February 2024
- exercised options over 3,438 shares of Rhythm PharmaceuticalsSEC Form 413 February 2024Common Stock · traded 9 February 2024 · filed 13 February 2024
- exercised options over 2,031 shares of Rhythm PharmaceuticalsSEC Form 413 February 2024Common Stock · traded 11 February 2024 · filed 13 February 2024
- ▼ sold on the open market 1,594 shares of Rhythm PharmaceuticalsSEC Form 413 February 2024Common Stock · traded 12 February 2024 · filed 13 February 2024
- ▼ sold on the open market 957 shares of Rhythm PharmaceuticalsSEC Form 413 February 2024Common Stock · traded 13 February 2024 · filed 13 February 2024
- returned to the issuer 41,500 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 418 April 2023Restricted Stock Units · traded 14 April 2023 · filed 18 April 2023
- was granted 41,500 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 418 April 2023Restricted Stock Units · traded 14 April 2023 · filed 18 April 2023
- ▼ sold on the open market 1,177 shares of Rhythm PharmaceuticalsSEC Form 416 February 2023Common Stock · traded 14 February 2023 · filed 16 February 2023
- ▼ sold on the open market 1,563 shares of Rhythm PharmaceuticalsSEC Form 414 February 2023Common Stock · traded 9 February 2023 · filed 14 February 2023
- exercised options over 2,031 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 414 February 2023Restricted Stock Units · traded 11 February 2023 · filed 14 February 2023
- exercised options over 2,031 shares of Rhythm PharmaceuticalsSEC Form 414 February 2023Common Stock · traded 11 February 2023 · filed 14 February 2023
- exercised options over 3,438 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 February 2023Restricted Stock Units · traded 9 February 2023 · filed 13 February 2023
- exercised options over 3,438 shares of Rhythm PharmaceuticalsSEC Form 413 February 2023Common Stock · traded 9 February 2023 · filed 13 February 2023
- ▼ sold on the open market 1,548 shares of Rhythm PharmaceuticalsSEC Form 413 February 2023Common Stock · traded 9 February 2023 · filed 13 February 2023
- was granted 41,500 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2023Restricted Stock Units · traded 1 February 2023 · filed 3 February 2023
- exercised options over 2,032 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 415 February 2022Restricted Stock Units · traded 11 February 2022 · filed 15 February 2022
- exercised options over 2,032 shares of Rhythm PharmaceuticalsSEC Form 415 February 2022Common Stock · traded 11 February 2022 · filed 15 February 2022
- ▼ sold on the open market 934 shares of Rhythm PharmaceuticalsSEC Form 415 February 2022Common Stock · traded 15 February 2022 · filed 15 February 2022
- was granted 13,750 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 411 February 2022Restricted Stock Units · traded 9 February 2022 · filed 11 February 2022
- was granted 82,500 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 411 February 2022Stock Option (Right to Buy) · traded 9 February 2022 · filed 11 February 2022
- was granted 8,125 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 416 February 2021Restricted Stock Units · traded 11 February 2021 · filed 16 February 2021
- was granted 48,750 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 416 February 2021Stock Option (Right to Buy) · traded 11 February 2021 · filed 16 February 2021
- was granted 100,000 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 46 October 2020Stock Option (Right to Buy) · traded 5 October 2020 · filed 6 October 2020
- was granted 70,000 shares of Trevi Therapeutics (a derivative holding)SEC Form 418 February 2020Stock Option (right to buy) · traded 13 February 2020 · filed 18 February 2020
- was granted 50,000 shares of Trevi Therapeutics (a derivative holding)SEC Form 45 June 2019Stock Option (right to buy) · traded 3 June 2019 · filed 5 June 2019
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.